148 related articles for article (PubMed ID: 2242543)
21. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.
Kiowski W; Sütsch G; Hunziker P; Müller P; Kim J; Oechslin E; Schmitt R; Jones R; Bertel O
Lancet; 1995 Sep; 346(8977):732-6. PubMed ID: 7658874
[TBL] [Abstract][Full Text] [Related]
22. Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog.
Redfield MM; Edwards BS; McGoon MD; Heublein DM; Aarhus LL; Burnett JC
Circulation; 1989 Sep; 80(3):651-7. PubMed ID: 2527645
[TBL] [Abstract][Full Text] [Related]
23. The potential role of endothelin as a vasoconstrictor substance in congestive heart failure.
Cody RJ
Eur Heart J; 1992 Nov; 13(11):1573-8. PubMed ID: 1464346
[TBL] [Abstract][Full Text] [Related]
24. Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs.
Choussat R; Hittinger L; Barbe F; Maistre G; Carayon A; Crozatier B; Su J
Cardiovasc Res; 1998 Sep; 39(3):580-8. PubMed ID: 9861300
[TBL] [Abstract][Full Text] [Related]
25. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
[TBL] [Abstract][Full Text] [Related]
26. Effects of an orally effective endothelin-A receptor antagonist in dogs with pacing-induced heart failure.
McConnell PI; Wang W; Zucker IH
Nebr Med J; 1996 Nov; 81(11):349-55. PubMed ID: 8979712
[TBL] [Abstract][Full Text] [Related]
27. [Level of endothelin increases in chronic congestive heart failure].
Halawa B
Kardiol Pol; 1993 Mar; 38(3):169-72; discussion 173. PubMed ID: 8230990
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
29. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation.
Lerman A; Kubo SH; Tschumperlin LK; Burnett JC
J Am Coll Cardiol; 1992 Oct; 20(4):849-53. PubMed ID: 1527295
[TBL] [Abstract][Full Text] [Related]
30. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC
Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038
[TBL] [Abstract][Full Text] [Related]
31. Endothelin in congestive heart failure.
Love MP; McMurray JJ
Basic Res Cardiol; 1996; 91 Suppl 1():21-9. PubMed ID: 8896740
[TBL] [Abstract][Full Text] [Related]
32. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril.
Galatius-Jensen S; Wroblewski H; Emmeluth C; Bie P; Haunsø S; Kastrup J
Cardiovasc Res; 1996 Dec; 32(6):1148-54. PubMed ID: 9015418
[TBL] [Abstract][Full Text] [Related]
33. Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure.
Wada A; Tsutamato T; Maeda Y; Kanamori T; Matsuda Y; Kinoshita M
Am J Physiol; 1996 May; 270(5 Pt 2):H1819-24. PubMed ID: 8928891
[TBL] [Abstract][Full Text] [Related]
34. Endothelin in human congestive heart failure.
Wei CM; Lerman A; Rodeheffer RJ; McGregor CG; Brandt RR; Wright S; Heublein DM; Kao PC; Edwards WD; Burnett JC
Circulation; 1994 Apr; 89(4):1580-6. PubMed ID: 8149524
[TBL] [Abstract][Full Text] [Related]
35. Reduced pulmonary metabolism of endothelin-1 in canine tachycardia-induced heart failure.
Dupuis J; Moe GW; Cernacek P
Cardiovasc Res; 1998 Sep; 39(3):609-16. PubMed ID: 9861303
[TBL] [Abstract][Full Text] [Related]
36. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure.
Onishi K; Ohno M; Little WC; Cheng CP
J Pharmacol Exp Ther; 1999 Mar; 288(3):1214-22. PubMed ID: 10027861
[TBL] [Abstract][Full Text] [Related]
37. Plasma endothelin-1 in acute myocardial infarction with heart failure.
Tomoda H
Am Heart J; 1993 Mar; 125(3):667-72. PubMed ID: 8438694
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure.
Tsutamoto T; Hisanaga T; Fukai D; Wada A; Maeda Y; Maeda K; Kinoshita M
Am J Cardiol; 1995 Oct; 76(11):803-8. PubMed ID: 7572659
[TBL] [Abstract][Full Text] [Related]
39. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure.
Cannan CR; Burnett JC; Lerman A
Circulation; 1996 Feb; 93(4):646-51. PubMed ID: 8640990
[TBL] [Abstract][Full Text] [Related]
40. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
